Milkhaus Laboratories Corporate Finance Deal

This announcement appears as a matter of record only

Milkhaus Laboratories

received $5,000,000 for
Phase 2 clinical trials from

Current Shareholders

FOCUS Regional Managing Partner William S. Lear assisted in the negotiations as the representative of Milkhaus Laboratories.
Inside the Deal
Deal Type: Corporate Finance
Client(s)
Milkhaus Laboratories
Providence, RI, U.S.A.
Transaction Partner(s)
Current Shareholder(s)
FOCUS Teams Involved